Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury

Abstract

BackgroundNeuroinflammation following spinal cord injury (SCI) results in prolonged neurological damage and locomotor dysfunction. Polarization of microglia is vital to regulation of neuroinflammation, although the underlying mechanisms have not yet been elucidated. Endocannabinoid receptor subtype 2 (CB2R) is reported to ameliorate neurodegeneration via immunomodulation activities. However, the underlying machinery in the context of SCI remains unclear.MethodsA lipopolysaccharide-induced microglia inflammation model and a mouse model of SCI were employed to investigate the regulatory role of CB2R in the polarization of microglia in response to excess neuroinflammation. Markers of inflammation and autophagy were measured by Western blot analysis, immunofluorescence, flow cytometry, and enzyme-linked immunosorbent assays. Histological staining with hematoxylin and eosin, Nissl, and Luxol® fast blue was conducted using commercial kits. The locomotor function of the hindlimbs of the experimental mice was evaluated with the Basso Mouse Scale, Louisville Swim Scale, and footprint assay.ResultsThe results showed that CB2R promoted M2 differentiation, increased interleukin (IL)-10 expression, and inhibited M1 differentiation with decreased expression of IL-1β and IL-6. CB2R activation also increased ubiquitination of the NLRP3 inflammasome and interacted with the autophagy-related proteins p62 and microtubule-associated proteins 1B light chain 3. Treatment with the CB2R activator JWH-133 reduced loss of myelin, apoptosis of neurons, and glial scarring, leading to improved functional recovery of the hindlimbs, while the CB2R antagonist AM630 produced opposite results.ConclusionTaken together, these results suggested that CB2R activation attenuated neuroinflammation targeting microglial polarization by promoting NLRP3 clearance, thereby facilitating functional recovery post-SCI.

Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1

“…On the contrary, glial cells express more CNR2. It has been reported the upregulation of the expression of CNR2 under neuroinflammation and neurodegeneration conditions in microglia cells, specifically after the stimulation with GM-CSF and IFNγ 21 Moreover, the activation of cannabinoid receptor type 2 mitigated the neuroinflammation inducing the reduction of NLRP3 22 . In addition, HIV studies conducted in 293T cells showed the inhibition of HIV-1 LTR by synthetic, selective agonists of cannabinoid receptor 2 23 .…”

Acupuncture combined with moxibustion mitigates spinal cord injury-induced motor dysfunction in mice by NLRP3-IL-18 signaling pathway inhibition

“…A 5 g weight impactor was dropped from a height of 5 cm onto the exposed dorsal surface of the spinal cord for contusion (Fig. 1 ) [ 27 ]. The dwell time was 0.5 s, and the compression was 1.5 mm.…”

An emerging role of inflammasomes in spinal cord injury and spinal cord tumor

“…Minocycline inhibited microglia activation, thus reducing NLRP3-related inflammation and promoting functional recovery after SCI ( 53 ). More recently, an increasing number of chemicals and molecules, such as trehalose ( 54 ), cannabinoid receptor-2 ( 55 ), zinc ( 56 ), melatonin ( 57 ), and dopamine ( 58 ), have been found to improve functional recovery after SCI by targeting NLRP3 inflammasome directly or indirectly.…”